EUROPEAN PATIENTS' FORUM - Luxembourg 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
Networking Rank (Reputation):300-400
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 6.000.000 65.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ABBVIE1
ACTELION PHARMACEUTICALS1
AMGEN LIMITED1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA AB1
BAYER PHARMA1
CSL BEHRING1
ELI LILLY AND COMPANY LIMITED1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN CANCER PATIENT COALITION1
F HOFFMANNLA ROCHE1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS1
ISTITUTO EUROPEO DI ONCOLOGIA1
JANSSEN PHARMACEUTICA NV1
KATHOLIEKE UNIVERSITEIT LEUVEN1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MINDBYTES1
MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND1
NOVARTIS PHARMA1
PFIZER LIMITED1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
STEINBEISSER PROJECT MANAGEMENT UG1
TAKEDA DEVELOPMENT CENTRE EUROPE1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UPPSALA UNIVERSITET1

Constancy:

Total number of partners: 32
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 32
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033

Alias institution names:

  • EUROPEAN PATIENTS' FORUM
  • FORUM EUROPEEN DES PATIENTS